Decreasing in vitro susceptibility of clinical Staphylococcus aureus isolates to vancomycin at the New York Hospital: Quantitative testing redux [5]

Clinical Infectious Diseases

Volumn 40, Issue 11, 2005, Pages 1705-1706

  Rhee, Kyu Y ^a   Gardiner, David F ^a   Charles, Macarthur ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERICIDAL ACTIVITY; DRUG EFFICACY; DRUG SENSITIVITY; ENDOCARDITIS; IN VITRO STUDY; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OSTEOMYELITIS; PRIORITY JOURNAL; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; HOSPITALS; HUMANS; NEW YORK CITY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TIME FACTORS; VANCOMYCIN;

EID: 19344373404     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/430175     Document Type: Letter

References (5)

1. Appelbaum PC, Bozdogan B. Vancomycin resistance in Staphylococcus aureus. Clin Lab Med 2004; 24:381-402.
2. Liu C, Chambers HF. Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob Agents Chemother 2003; 47:3040-5.
3. Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RC Jr, Eliopoulos GM. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 2004; 42:2398-402.
4. Schlichter JG, MacLean H. A method of determining the effective therapeutic level in the treatment of subacute bacterial endocarditis with penicillin: a preliminary report. Am Heart J 1947; 34:209-11.
5. NCCLS. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 4th ed. Approved standard. NCCLS document M7-A4. Villanova, PA: NCCLS, 2000.